Begin monitoring your vision at home using the mVT® Service.
If you have, or are at high-risk for, Age-Related Macular Degeneration (AMD) or Diabetic Eye Disease, you may benefit from Home Vision Monitoring.
Ask your licensed eye-care professional for a prescription.
Vital Art and Science, LLC has developed the mVT® Service for patients with maculopathy who are interested in monitoring their vision at home in-between office visits with their Ophthalmologist, Retina Specialist, and Optometrist. The purpose of mVT® Service is to detect early vision changes related to retinal diseases which is critical for the expedient treatment of these diseases and better patient outcome.
The Home Vision Monitoring App (mVT®) is an FDA Cleared Ophthalmic Medical Device, available on an Apple iPad®, iPhone®, or iPod®. Patients test twice a week and any change in vision function will trigger an ‘Alert’ to their eye-care professional, allowing for earlier assessment and possible therapy.
The mVT® Service is intended for the detection and characterization of central three degrees metamorphopsia (visual distortion) in patients with maculopathy, including age-related macular degeneration and diabetic eye disease, and as an aid in monitoring disease factors causing metamorphopsia. It is intended to be used by patients who have the capability to regularly perform a simple self-test at home.
Ask your licensed eye-care professional if Home Vision Monitoring is right for you.
*Certain functions and uses may not be applicable to clinical study patients.*